Metraipolis › archive › dc_e8d61566b995

Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain — Europe PMC PMID:34424927

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34424927
DOI
10.1371/journal.pone.0255975
License (as archived)
CC0-1.0
Archived
2026-11-03T04:49:57.607Z
SHA-256 of the archived text
dd3c47e608defe02d47167f456ab2ede20584663043d624a955e30c27b713c09
Stable URL of this page
https://metraipolis.com/documento/dc_e8d61566b995

How to cite

Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain — Europe PMC PMID:34424927 — Europe PMC (en), https://europepmc.org/article/MED/34424927 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_e8d61566b995 (Metraipolis archive dc_e8d61566b995, sha256 dd3c47e608defe02d47167f456ab2ede20584663043d624a955e30c27b713c09)
BibTeX
@misc{dce8d61566b995,
  title = {Intravesical CD74 and CXCR4, macrophage migration inhibitory factor (MIF) receptors, mediate bladder pain — Europe PMC PMID:34424927},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34424927},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_e8d61566b995; sha256 dd3c47e608defe02d47167f456ab2ede20584663043d624a955e30c27b713c09},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34424927. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: Activation of intravesical protease activated receptor 4 (PAR4) leads to release of urothelial macrophage migration inhibitory factor (MIF). MIF then binds to urothelial MIF receptors to release urothelial high mobility group box-1 (HMGB1) and elicit bladder hyperalgesia. Since MIF binds to multiple receptors, we investigated the contribution of individual urothelial MIF receptors to PAR4-induced HMGB1 release in vivo and in vitro and bladder pain in vivo. Methodology/principal findings: We tested the effect of intravesical pre-treatment with individual MIF or MIF receptor (CD74, CXCR4, CXCR2) antagonists on PAR4-induced HMGB1 release in vivo (female C57/BL6 mice) and in vitro (primary human urothelial cells) and on PAR4-induced bladder hyperalgesia in vivo (mice). In mice, PAR4 induced HMGB1 release and bladder hyperalgesia through activation of intravesical MIF receptors, CD74 and CXCR4. CXCR2 was not involved in these effects. In primary urothelial cells, PAR4-induced HMGB1 release through activation of CD74 receptors. Micturition parameters in mice were not changed by any of the treatments. Conclusions/significance: Urothelial MIF receptors CD74 and CXCR4 mediate bladder pain through release of urothelial HMGB1. This mechanism may set up persistent pain loops in the bladder and warrants further investigation. Urothelial CD74 and CXCR4 may provide novel targets for interrupting bladder pain.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2021 (prima pubblicazione 2021-08-23).
Identificativi: PMID 34424927 · PMCID PMC8382170 · DOI 10.1371/journal.pone.0255975.
Pagina: https://europepmc.org/article/MED/34424927 — https://doi.org/10.1371/journal.pone.0255975. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-03T04:42:17.701Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.